Question Bank › Staircase quarter: best recent period just repor

Staircase quarter: best recent period just reported, and the next step up is already in hand

Calls Tested
457
Answered YES
4
Hit Rate
0.9%
rare by design

VolitionRx Limited (VNRX) — this company's answers

NO on the Q1 2022 call 2022-05-12 F
The model's full reasoning — Q1 2022 call → NOWe need to determine if management presents the just-reported period as one of the strongest stretches in recent history, and also says the next period will be bigger, with reasons already in hand. Let's analyze the transcript. Management (Cameron Reynolds, Tom Butera, Terig Hughes) discuss Q1 2022 results. Key points: - Terig: "We ended the quarter with cash and cash equivalents of approximately $23.7 million compared with $20.6 billion at the end of 2021." (Note: likely typo, but anyway) "This cash position includes an upfront milestone payments of $10 million received from Heska Corporation in relation to the licensing and supply agreement executed with them on March 28, 2022." - Terig: "Total operating expenses for the quarter was $7.8 million compared to $6.1 million in the first quarter of 2021." Increase due to higher personnel costs etc. - Revenue: "$114,000 versus $25,000 for the first quarter the prior year." Increase from initial sales of Nu.Q Discover, Nu.Q Vet tests to SAGE, and H3.1 Q. - Net loss: $7.7 million vs $6.1 million. - Terig: "As mentioned previously, we received an upfront milestone payment of $10 million in cash from Heska Corporation. This was not only a milestone payment, but also a company milestone. The combination of much work across the Company and truly marked the beginning of our commercial journey." - Tom Butera: "This first quarter of 2022 really has been a breakthrough time for bullish in veterinary." (Probably "for Volition in veterinary") "I am so proud to update all of you on the call today. I honestly could not be prouder of our achievement in securing a global licensing and supply contract, with one of the industry's leading companies Heska Corporation." - Tom: "When we announced this deal in March, I commented about Heska very much sharing our philosophy, our work ethic and vision as to how Nu.Q Vet can really help save lives and improve outcomes for millions of pets worldwide. And I have to say that since that I believe this even more so today. We have many work streams up and running from technical transfer and logistics to sales and marketing and are making tremendous progress towards the launch." - Tom: "As a reminder, our executed agreement with Heska provides exclusive rights to sell Volition's Nu.Q Vet Cancer Test for companion animals at the point of care.

← Back to the full VNRX analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management present the just-reported period as one of the STRONGEST STRETCHES OF BUSINESS THE COMPANY HAS HAD IN ITS RECENT HISTORY — and, in the same breath, tell investors that the PERIOD DIRECTLY AHEAD IS SET TO BE BIGGER STILL, grounding that near-term step-up in things the company ALREADY HAS IN HAND rather than in hopes about the market? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent staircase pattern with BOTH halves present: (1) THE PERIOD JUST FINISHED WAS A HIGH POINT, IN MANAGEMENT'S OWN TELLING. Management characterizes the recent period's business — its orders, volumes, customers, activity, output, wins, or overall performance — as among the strongest the company has recently produced: a record or near-record stretch, a clear high-water mark versus the company's own recent past, or plainly described as the best the business has been running in a long while. The strength must be about real activity that already happened, in whatever terms fit the industry, and must be management's own framing rather than a number an analyst characterizes as strong. (2) THE VERY NEXT STRETCH IS DESCRIBED AS BIGGER, FOR REASONS ALREADY IN HAND. Management indicates that the period immediately ahead — the coming quarter, season, or comparable near-term stretch — is expected to step ABOVE the high point just reported, and supports that expectation with things that already exist or are already committed: orders or bookings already received, work already sold or scheduled, customers already ramping, capacity or product already coming online, commitments already signed, or activity already running at a higher pace than the reported period's average. The essence is that the next step of the staircase is already under the company's feet — management can point to it — rather than something that requires demand to improve, markets to recover, or new business to be won first. Answer NO if the reported period is weak, mixed, merely in-line, or only recovering toward past levels, with no recent high point in management's own framing. NO if management describes the strong period as a peak, one-time bulge, pull-forward, or level it expects to come back down from. NO if the next period is guided flat, down, or merely 'continued strong' without a described step above the level just reported. NO if the expected step-up rests mainly on hoped-for demand, seasonality alone, market recovery, pipeline conversion, or deals not yet closed rather than on business or capability already in hand. NO if either half appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
UPLD Upland Software, Inc. Q4 2017 2018-03-08 C+
GPOR Gulfport Energy Corporation Q4 2016 2017-02-14 A
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

GPOR · Q4 2016 → YESThe question is: Does management present the just-reported period as one of the strongest stretches of business the company has had in its recent history — and, in the same breath, tell investors that...YES The transcript shows management framing 2016 as a defining year with record production growth (32% YoY) and reserves increases, calling it a high point in their own words ("another year of record production growth"). For 2017, they announce a $1B–$1.1B capital budget 45–53% higher production growth, grounded in the SCOOP acquisition (already closed or closing), doubled Utica rig count, and existing acreage/hedges—not market hopes. They also note Q1 2017 activity ramping to four net wells turned-to-sales.
UPLD · Q4 2017 → YESThe question is: Does management present the just-reported period as one of the STRONGEST STRETCHES OF BUSINESS THE COMPANY HAS HAD IN ITS RECENT HISTORY — and, in the same breath, tell investors that...YES Management frames Q4 as an "incredibly strong close" with a "record 44% revenue growth" and 1,300-basis-point EBITDA margin expansion to 35%, calling it the 14th consecutive quarter of beating guidance and part of an "outstanding year.
HPP · Q4 2015 → YESThe question is: Does management present the just-reported period as one of the strongest stretches of business the company has had in its recent history — and, in the same breath, tell investors that...YES Victor Coleman explicitly frames 2015 as a “banner year” and “landmark year” with “strong fourth quarter earnings,” “all-time high” demand in Q4, and “impressive” results that “rounded out” the year.

More from the question bank

Selling the shovels to a customer who just gCheap-to-serve incremental businessConviction backed by things in handQ&A has flipped from problems to possibilitiRoom to raise the ceilingBreak from their own historyAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.